TrivarX Limited (ASX:TRI)

Market Cap	6.82M
Revenue (ttm)	1.13M
Net Income (ttm)	-943.23K
Shares Out	619.83M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	146,020
Average Volume	1,098,289
Open	0.0100
Previous Close	0.0105
Day's Range	0.0100 - 0.0110
52-Week Range	0.0070 - 0.0240
Beta	0.70
RSI	58.56
Earnings Date	Aug 28, 2025

About TrivarX

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia.

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1987
• Employees: 6
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TRI

Financial Performance

In 2025, TrivarX's revenue was 1.13 million, an increase of 27.02% compared to the previous year's 888,829. Losses were -943,231, -34.25% less than in 2024.